Oman vs Sur: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Oman
99.0%
in 2025
Sur
52.0%
in 2025
Oman rank
1st
Sur rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Oman
- Sur
How they compare
Oman currently reports 99.0% against 52.0% in Sur, a difference of 47.0%.
That makes Oman's figure about 1.9 times Sur's.
Across all 26 years both countries report, Oman has been ahead every year.
Oman ranks 1st and Sur ranks 1st of 194 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.8% | 0.0% | 97.8% | Oman |
| 2010s | 98.9% | 18.0% | 80.9% | Oman |
| 2020s | 98.8% | 45.7% | 53.2% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Oman or Sur?
- Oman, at 99.0% against 52.0% in Sur as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Oman and Sur?
- 47.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Sur?
- 26 years are reported by both, from 2000 to 2025.
- How do Oman and Sur rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Oman ranks 1st and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.